Open Access & Peer-Reviewed
Submit ManuscriptThe Journal of Thrombosis and Treatments operates with a transparent article processing charge model built for researchers, clinicians, and institutions that expect quality, predictability, and measurable publishing value. APCs are applied only after editorial acceptance, and each fee supports expert peer review management, production quality, metadata preparation, DOI registration, and long term open access hosting. Our objective is simple: help important thrombosis and anticoagulation evidence move quickly from manuscript to trusted publication while giving authors and finance teams clear budget visibility from the beginning of the submission journey.
Fees are aligned to manuscript complexity, review intensity, and production scope. All charges are in USD and are invoiced only after final acceptance. This approach lets corresponding authors, grants offices, and institutional procurement teams plan costs without uncertainty.
| Article Type | APC Fee | Publishing Scope |
|---|---|---|
| Original Research Article | USD 1,850 | Comprehensive clinical or translational thrombosis studies with robust methods, outcomes, and data interpretation. |
| Review Article | USD 1,950 | Broad evidence synthesis for thrombosis prevention, diagnosis, management, and treatment optimization. |
| Systematic Review and Meta Analysis | USD 2,100 | Protocol driven pooled evidence analysis requiring deeper methodological and statistical editorial handling. |
| Case Report or Case Series | USD 950 | Rare or high impact clinical presentations that provide practical therapeutic insight for frontline care. |
| Brief Communication | USD 750 | Concise, high value findings where fast communication is important to the thrombosis community. |
| Editorial or Commentary | USD 450 | Expert perspective on evidence direction, clinical policy implications, and research priorities. |
| Letter to the Editor | USD 350 | Focused scientific discussion, critique, and methodological clarification after publication. |
Authors choose JTT not only for publication, but for dependable editorial execution and stronger post publication discoverability. APC revenue sustains the workflows that protect quality and improve long term research impact.
Dedicated editorial staff manage submission screening, reviewer invitations, response tracking, and decision preparation. This reduces avoidable delays and ensures each manuscript receives disciplined, fair, and accountable process oversight.
Review assignments are matched to hematology, vascular medicine, anticoagulation, interventional, and translational thrombosis expertise so authors receive rigorous and relevant feedback that improves scientific clarity and clinical usefulness.
Accepted papers are prepared for consistent digital presentation, reference accuracy, and indexing compatibility. Well structured metadata supports discoverability in search engines, bibliographic systems, and institutional repositories.
APCs maintain long term hosting and technical upkeep so your thrombosis research remains accessible to clinicians, educators, policy teams, and investigators without subscription barriers at any stage of future evidence use.
JTT supports equitable publishing through structured discount and waiver options. Active membership can reduce APC commitments substantially, and institutional partnerships may provide additional cost support for affiliated authors. We also review documented financial constraints on a case by case basis to ensure important science is not excluded by budget limits.
Fee assistance decisions are handled independently from editorial decisions. Manuscripts are assessed on scientific quality, methodological strength, and practical contribution to thrombosis care. Authors are encouraged to raise waiver questions early, ideally during submission or major revision, so billing pathways are aligned before acceptance.
The process below is designed for predictable execution from submission through publication, helping both scientific and finance stakeholders stay aligned.
Provide manuscript files, author details, ethics declarations, and funding information through the preferred submission route.
Peer review outcomes are consolidated into clear editorial guidance for revision, acceptance, or decline based on scientific merit.
After acceptance, APC documentation is issued to the designated payer with references needed for institutional processing.
Production, metadata, and quality checks are finalized and the article is released for global access and citation visibility.
These responses address the most common operational and budget questions from clinical researchers, principal investigators, and publication managers.
APCs are charged only after editorial acceptance. There is no submission stage fee for standard manuscripts.
Yes. JTT supports institutional invoicing and can include procurement references required by finance departments.
No. Editorial evaluation is independent and based on research quality, methodological rigor, and relevance to thrombosis care.
For APC documentation, invoice format requests, or waiver clarification, contact the journal support desk at [email protected].
If your team is preparing a manuscript on thrombosis prevention, anticoagulation outcomes, interventional strategy, or coagulation science, JTT provides a transparent APC framework and a disciplined publication process from decision to release. For support on billing routes, documentation, or fee assistance, contact [email protected].
